Product Image

Genante®   
of Life

An innovative support for couples’ Fertility

Based on REVIFAST® technology

  • Patented Formulation with Prolonged Absorption
  • Targeted Mechanism of Action "Mitochondrial Enhancement"
  • Substantiated by Preclinical and Clinical Studies
What is it?

GENANTE® is a food supplement based on Revifast® (an extract from Polygonum), trans- Resveratrol, Extrafolate-S®(Calcium L-methylfolate), Vitamin B6, Vitamin B12 and Vitamin D.      
Specially Formulated by Fertility Experts with Patented Technology.

When to use?
Genante® is a support for couples planning a pregnancy
  • For couples planning a pregnancy
  • For couples undergoing Assisted Reproductive Technology (ART)
  • Support for both women and men
  • To preserve Ovarian Reserve
How to use?

The recommended daily dose is two tablets per day, to be swallowed with water, one in the morning and one in the evening. The two daily intakes should preferably be spaced at least 10 hours apart, possibly on an empty stomach.  


Beneficial effects are noticeable with continuous use of the product for at least 3 months, which may be extended according to the recommendation of the medic.

Bollo posologia
Patented Formula!

The patented formulation of GENANTE®, based on REVIFAST® represents a therapeutic opportunity to optimize Gametogenesis by acting on Mitochondria.

a
REVIFAST® Technology

REVIFAST® is a patented formulation based on Resveratrol supported on a magnesium hydroxide matrix that dissolves at gastric pH, thus allowing full exploitation of the real pharmacological enhancement of this polyphenol.

Resveratrol possesses numerous beneficial properties and is a molecule capable of performing critical biological functions in the context of human reproduction.

In women of childbearing age, Resveratrol enhances sensitivity to gonadotropins and stimulates folliculogenesis.      
In men, it improves seminal parameters.

LEARN MORE

The efficacy and safety of Genante® have been demonstrated in Clinical Studies conducted on:      
Infertile Women undergoing Assisted Reproductive Technology (ART)      
Men with idiopathic infertility.

 

CLINICALLY TESTED
Learn more about clinical studies:
CLINICAL STUDIES